NT
NTRBW
NutriBand Inc.
$1.27
+14.41%
$15.4M
No data for this timeframe.
Vol
Market Cap$15.4M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$366.00
Inst. Activity1 buys / 1 sells
SEC Reports2
Exchange Nasdaq·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. NV·CIK 0001676047·Prev Close $1.11
Recent Activity
May 18, 2026
SEC
Nutriband Inc. filed Amendment No. 1 to its 10-K for FY2026 solely to add Exhibit 97.1, the Executive Compensation Clawb
10-K/A — Impact 1/10
Apr 7, 2026
SEC
NutriBand Inc. announced the selection of a commercial worldwide brand name for its lead product, an abuse-deterrent fen
8-K — Impact 3/10
Inst.
BANK OF AMERICA CORP — DOUBLED
200 shares ($340.00)
Inst.
UBS Group AG — NEAR_EXIT
15 shares ($26.00)
May 15, 2026
other
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
AI Products Showcase
Latest Reports
NEUTRAL
10-K/A
1/10
Nutriband Inc. filed Amendment No. 1 to its 10-K for FY2026 solely to add Exhibit 97.1, the Executive Compensation Clawb
May 18, 2026
NEUTRAL
8-K
3/10
NutriBand Inc. announced the selection of a commercial worldwide brand name for its lead product, an abuse-deterrent fen
Apr 7, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $340.00 | DOUBLED |
| UBS Group AG | $26.00 | NEAR_EXIT |
2 institutional holders with $366.00 total value (215 shares) as of 2025-Q3. Top holders: BANK, UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 200 | $340.00 | 92.9% | DOUBLED +100.0% |
| 2 | UBS Group AG | 15 | $26.00 | 7.1% | NEAR_EXIT -99.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | 100 | 200 | +100.0% | $340.00 | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 2,177 | 15 | -99.3% | $26.00 | 2025-Q3 |
| UBS Group AG | DOUBLED | 215 | 2,374 | +1004.2% | $3.6K | 2025-Q1 |
| UBS Group AG | TRIM | 415 | 215 | -48.2% | $301.00 | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 15, 2026
other
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
AI Products Showcase
Apr 22, 2026
other
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
CEO Gareth Sheridan appears as guest on the Jack Neel Podcast
Mar 30, 2026
contract
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Name chosen for AVERSA Fentanyl commercial product